AnnJi Pharmaceutical is an R&D based new drug company. We specialized in early stages development of novel small chemical entities; from lead optimization to clinical proof of concept studies and focus on dermatology and neurology disease areas.

Our pipeline includes exciting first-in-class and best-in-class molecules that were designed by our chemists specific for disease targets that have shown promise to treat disease conditions of high unmet medical needs; such as chemotherapy induced peripheral neuropathy and topical treatment of chronic skin diseases.